Senolytics in the treatment of diabetic retinopathy

Senolytics in the treatment of diabetic retinopathy

Diabetic retinopathy (DR) is the most common complication of diabetes. DR is characterized by damage to retinal vasculature resulting in vision impairment and, if untreated, could eventually lead to blindness. The pathogenic mechanism of DR is complex; emerging studies suggest that premature senesce...

Full description

Bibliographic Details
Main Authors: Jannah Waled Hassan, Ashay D. Bhatwadekar
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
diabetic retinopathy
senolytics
diabetes
inflammation
pharmacological agents
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.896907/full

Similar Items

Similar Items